Variant report
Variant | nsv607721 |
---|---|
Chromosome Location | chr7:85500421-85512030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181841567 | chr7:85503834-85503835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144250213 | chr7:85503853-85503854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569170642 | chr7:85503888-85503889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185897307 | chr7:85503910-85503911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548514351 | chr7:85503915-85503916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs567509160 | chr7:85504067-85504068 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550272248 | chr7:85504089-85504090 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12704182 | chr7:85504101-85504102 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs12704183 | chr7:85504117-85504118 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs188742990 | chr7:85504119-85504120 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570487889 | chr7:85504126-85504127 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181258718 | chr7:85504129-85504130 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12704184 | chr7:85504160-85504161 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs148743712 | chr7:85504184-85504185 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12704185 | chr7:85504188-85504189 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs186363825 | chr7:85504270-85504271 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572385656 | chr7:85504285-85504286 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12704186 | chr7:85504303-85504304 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs374852820 | chr7:85504308-85504309 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191116601 | chr7:85504337-85504338 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74407676 | chr7:85504353-85504354 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12704187 | chr7:85504393-85504394 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs144334554 | chr7:85504403-85504404 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562632659 | chr7:85504417-85504418 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375223085 | chr7:85504453-85504454 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532350990 | chr7:85504491-85504492 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548474687 | chr7:85504493-85504494 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143648101 | chr7:85504497-85504498 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35385818 | chr7:85504499-85504500 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527263357 | chr7:85504513-85504514 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551923914 | chr7:85504521-85504522 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570521142 | chr7:85504554-85504555 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537498902 | chr7:85504557-85504558 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549473027 | chr7:85504582-85504583 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10808063 | chr7:85504603-85504604 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs528668931 | chr7:85504774-85504775 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554030882 | chr7:85504777-85504778 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572693354 | chr7:85504785-85504786 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537601584 | chr7:85504787-85504788 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539819122 | chr7:85504799-85504800 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112430859 | chr7:85504828-85504829 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557820021 | chr7:85504832-85504833 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576395496 | chr7:85504845-85504846 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10808064 | chr7:85504888-85504889 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs562185119 | chr7:85504952-85504953 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10808065 | chr7:85504956-85504957 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs112615410 | chr7:85504994-85504995 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs10952862 | chr7:85505010-85505011 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs35501625 | chr7:85505032-85505033 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12704188 | chr7:85505077-85505078 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Williams-beuren syndrome | 16826523 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:85503800-85504000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr7:85504000-85504800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr7:85504200-85504800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr7:85504800-85505000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr7:85504800-85505200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr7:85505200-85505400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr7:85505400-85505600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |